Back to Results
First PageMeta Content
Breakthrough therapy / Gilead Sciences / Specialty drugs / Cyclopropanes / Healthcare-associated infections / Sofosbuvir / Ledipasvir / Hepatitis C / Interferon / Peginterferon alfa-2a / Hepatitis / Cirrhosis


Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio
Add to Reading List

Document Date: 2016-08-04 23:27:22


Open Document

File Size: 148,00 KB

Share Result on Facebook
UPDATE